300497 富祥股份
交易中 07-06 14:20:03
资讯
新帖
简况
富祥股份（300497）披露全资子公司获得托拉塞米原料药上市申请批准通知书，7月2日股价下跌3.17%
证券之星 · 07-02
富祥股份（300497）披露全资子公司获得托拉塞米原料药上市申请批准通知书，7月2日股价下跌3.17%
富祥股份（300497）披露控股股东部分股份解除质押公告，6月30日股价上涨3.65%
证券之星 · 06-30
富祥股份（300497）披露控股股东部分股份解除质押公告，6月30日股价上涨3.65%
公司问答丨富祥股份：公司生产的电子级三氮唑纯度可达到99.99% 可切入电子化学品半导体清洗剂的供应链
格隆汇 · 06-25
公司问答丨富祥股份：公司生产的电子级三氮唑纯度可达到99.99% 可切入电子化学品半导体清洗剂的供应链
富祥股份：关键中间体三氮唑可用于医药、电子化学品等领域
证券之星 · 06-25
富祥股份：关键中间体三氮唑可用于医药、电子化学品等领域
富祥股份（300497）披露为控股子公司提供担保进展公告，6月23日股价上涨8.23%
证券之星 · 06-23
富祥股份（300497）披露为控股子公司提供担保进展公告，6月23日股价上涨8.23%
富祥股份涨6.06%，华鑫证券二个月前给出“买入”评级
证券之星 · 06-22
富祥股份涨6.06%，华鑫证券二个月前给出“买入”评级
每周股票复盘：富祥股份（300497）预计上半年净利1.65亿至2.15亿元
证券之星 · 06-21
每周股票复盘：富祥股份（300497）预计上半年净利1.65亿至2.15亿元
富祥股份（300497）披露2026年半年度业绩预告，6月18日股价上涨6.92%
证券之星 · 06-18
富祥股份（300497）披露2026年半年度业绩预告，6月18日股价上涨6.92%
富祥股份：预计2026年1-6月归属净利润盈利1.65亿元至2.15亿元
证券之星 · 06-18
富祥股份：预计2026年1-6月归属净利润盈利1.65亿元至2.15亿元
富祥股份涨6.92%，华鑫证券二个月前给出“买入”评级
证券之星 · 06-18
富祥股份涨6.92%，华鑫证券二个月前给出“买入”评级
富祥股份(300497.SZ)发预盈，预计上半年归母净利润1.65亿元至2.15亿元，同比扭亏为盈
智通财经 · 06-18
富祥股份(300497.SZ)发预盈，预计上半年归母净利润1.65亿元至2.15亿元，同比扭亏为盈
富祥股份：《电动汽车用动力蓄电池安全要求》（GB 38031-2025）将于2026年7月1日起正式实施
证券之星 · 06-18
富祥股份：《电动汽车用动力蓄电池安全要求》（GB 38031-2025）将于2026年7月1日起正式实施
富祥股份：公司是国内舒巴坦领域唯一通过国际规范市场认证的供应商
证券日报网 · 06-14
富祥股份：公司是国内舒巴坦领域唯一通过国际规范市场认证的供应商
富祥股份：2022年至2025年，公司累计研发投入约3.09亿元
证券日报网 · 06-14
富祥股份：2022年至2025年，公司累计研发投入约3.09亿元
富祥股份：聚焦高附加值原料药，持续深耕、巩固并扩大在既有医药领域的优势地位
证券日报网 · 06-14
富祥股份：聚焦高附加值原料药，持续深耕、巩固并扩大在既有医药领域的优势地位
富祥股份：公司是国内首家实现丝状真菌蛋白千吨级产业化的企业
证券日报网 · 06-14
富祥股份：公司是国内首家实现丝状真菌蛋白千吨级产业化的企业
富祥股份：到2035年全球替代蛋白市场规模有望达到2900亿美元
证券日报网 · 06-14
富祥股份：到2035年全球替代蛋白市场规模有望达到2900亿美元
【机构调研记录】东北证券调研富祥股份、凌玮科技等4只个股（附名单）
证券之星 · 06-08
【机构调研记录】东北证券调研富祥股份、凌玮科技等4只个股（附名单）
【机构调研记录】宏利基金调研富祥股份
证券之星 · 06-08
【机构调研记录】宏利基金调研富祥股份
【私募调研记录】中欧瑞博调研富祥股份
证券之星 · 06-08
【私募调研记录】中欧瑞博调研富祥股份
加载更多
公司概况
公司名称：
江西富祥药业股份有限公司
所属行业：
医药制造业
上市日期：
2015-12-22
主营业务：
江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售。公司的主要产品是β-内酰胺酶抑制剂、碳青霉烯类（培南系列）药物、抗病毒药物中间体、碳酸亚乙烯酯（VC）、氟代碳酸乙烯酯（FEC）、微生物蛋白、氨基酸水溶肥。公司未冉蛋白成功入选国家工信部首批“生物制造标志性产品”，并荣获“十四五”轻工业先进科技创新成果目录认定。
发行价格：
15.33
{"stockData":{"symbol":"300497","market":"SZ","secType":"STK","nameCN":"富祥股份","latestPrice":20.89,"timestamp":1783318803000,"preClose":21.86,"halted":0,"volume":40496849,"delay":0,"changeRate":-0.0444,"floatShares":453000000,"shares":539000000,"eps":0.0073,"marketStatus":"交易中","change":-0.97,"latestTime":"07-06 14:20:03","open":21.41,"high":21.91,"low":20.89,"amount":864000000,"amplitude":0.0467,"askPrice":20.9,"askSize":46,"bidPrice":20.89,"bidSize":129,"shortable":0,"etf":0,"ttmEps":0.0073,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1783321200000},"marketStatusCode":2,"adr":0,"adjPreClose":21.86,"symbolType":"stock","openAndCloseTimeList":[[1783301400000,1783308600000],[1783314000000,1783321200000]],"highLimit":24.05,"lowLimit":19.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":538648934,"isCdr":false,"pbRate":5.24,"roa":"--","peRate":2861.643836,"roe":"2.76%","epsLYR":-0.1,"committee":0.071384,"marketValue":11252000000,"turnoverRate":0.0895,"status":1,"floatMarketCap":9454000000},"requestUrl":"/m/hq/s/300497","defaultTab":"news","newsList":[{"id":"2648685058","title":"富祥股份（300497）披露全资子公司获得托拉塞米原料药上市申请批准通知书，7月2日股价下跌3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685058","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685058?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:32","pubTimestamp":1783002738,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，富祥股份报收于22.6元，较前一交易日下跌3.17%，最新总市值为121.73亿元。该股当日开盘23.11元，最高24.18元，最低22.5元，成交额达19.54亿元，换手率为18.67%。近日，江西富祥药业股份有限公司发布公告称，其全资子公司江西祥太生命科学有限公司收到国家药品监督管理局核准签发的托拉塞米原料药《化学原料药上市申请批准通知书》，批准该原料药在国内市场上市销售。审批结论为符合药品注册有关要求，批准注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647552195","title":"富祥股份（300497）披露控股股东部分股份解除质押公告，6月30日股价上涨3.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647552195","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647552195?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:20","pubTimestamp":1782829234,"startTime":"0","endTime":"0","summary":"公司于近日披露《关于控股股东部分股份解除质押的公告》。公告显示，江西富祥药业股份有限公司控股股东、实际控制人、董事长包建华先生近日解除质押其持有的公司股份8,530,000股，占其所持股份比例7.87%，占公司总股本比例1.58%，质押起始日为2023年6月16日，解除日期为2026年6月29日，质权人为赣州银行股份有限公司景德镇分行。本次解除质押后，包建华先生累计质押公司股份27,370,000股，占其所持股份比例25.25%，占公司总股本比例5.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646682722","title":"公司问答丨富祥股份：公司生产的电子级三氮唑纯度可达到99.99% 可切入电子化学品半导体清洗剂的供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2646682722","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646682722?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:28","pubTimestamp":1782372509,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","159582","300497","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646825046","title":"富祥股份：关键中间体三氮唑可用于医药、电子化学品等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2646825046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646825046?lang=zh_cn&edition=full","pubTime":"2026-06-25 11:36","pubTimestamp":1782358588,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥股份(300497)06月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在近期披露的半年报顶增公告中说，重点攻关关键中间体跨领域应用。请问是什么领域，进展如何？富祥股份回复：尊敬的投资者您好，公司关键中间体三氮唑现有500吨/年产能，其中150吨产能自用，配套他唑巴坦原料药生产，剩余350吨产能可以对外销售，产品可用于医药、电子化学品等领域。公司生产的电子级三氮唑纯度可达到99.99%，可切入电子化学品半导体清洗剂的供应链。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500018373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","159938","BK1574","BK1161","09939","BK0239","300497","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645834041","title":"富祥股份（300497）披露为控股子公司提供担保进展公告，6月23日股价上涨8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645834041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645834041?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:04","pubTimestamp":1782223460,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，富祥股份报收于22.36元，较前一交易日上涨8.23%，最新总市值为120.44亿元。近日，富祥股份披露《关于公司为控股子公司提供担保进展的公告》。公告显示，江西富祥药业股份有限公司为控股子公司富祥益海嘉里（富裕）生物科技有限公司向广发银行股份有限公司盘锦分行申请的44,800万元综合授信提供担保，公司按70%持股比例提供连带责任保证担保，担保金额为31,360万元本金及相关费用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645040223","title":"富祥股份涨6.06%，华鑫证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645040223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645040223?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:49","pubTimestamp":1782118164,"startTime":"0","endTime":"0","summary":"今日富祥股份涨6.06%，收盘报20.66元。2026年3月27日，华鑫证券研究员胡博新发布了对富祥药业的研报《公司事件点评报告：新业务迎来收获阶段，业绩大幅扭亏》，该研报对富祥药业给出“买入”评级。研报中预测公司2025-2027年收入分别为11.86、21.63、23.64亿元，EPS分别为-0.09、1.11、1.16元，当前股价对应PE分别为-195.8、16.6、15.9倍，考虑到新能源业务的持续扭亏以及微生物蛋白项目投产，首次覆盖，给予“买入”投资评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200023947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095838","title":"每周股票复盘：富祥股份（300497）预计上半年净利1.65亿至2.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645095838?lang=zh_cn&edition=full","pubTime":"2026-06-21 01:21","pubTimestamp":1781976069,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，富祥股份报收于19.48元，较上周的15.77元上涨23.53%。本周，富祥股份6月18日盘中最高价报19.98元。来自业绩披露要点：富祥股份预计2026年上半年归属净利润盈利1.65亿元至2.15亿元。来自公司公告汇总：富祥股份2026年半年度业绩预告显示，净利润同比增幅达2487%至3204%，实现扭亏为盈。业绩披露要点富祥股份发布业绩预告，预计2026年1-6月扣非后净利润盈利1.61亿元至2.1亿元。扣除非经常性损益后的净利润预计盈利16,100万元至21,050万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300497","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644812230","title":"富祥股份（300497）披露2026年半年度业绩预告，6月18日股价上涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644812230","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644812230?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:08","pubTimestamp":1781791702,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，富祥股份报收于19.48元，较前一交易日上涨6.92%，最新总市值为104.93亿元。该股当日开盘18.22元，最高19.98元，最低17.98元，成交额达14.05亿元，换手率为15.95%。江西富祥药业股份有限公司于2026年6月18日发布2026年半年度业绩预告，预计2026年1月1日至6月30日归属于上市公司股东的净利润为盈利16,500万元至21,450万元，较上年同期亏损691.12万元实现扭亏为盈，同比增长2487%至3204%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300497","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644470648","title":"富祥股份：预计2026年1-6月归属净利润盈利1.65亿元至2.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644470648","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644470648?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:47","pubTimestamp":1781772430,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥股份发布业绩预告，预计2026年1-6月归属净利润盈利1.65亿元至2.15亿元。2026年上半年公司前述产品销售量价齐增,推动公司业绩大幅增长且扭亏为盈。富祥股份2026年一季报显示，一季度公司主营收入3.58亿元，同比上升53.09%；归母净利润6119.55万元，同比上升2633.39%；扣非净利润6025.72万元，同比上升366.63%；负债率49.34%，财务费用1734.83万元，毛利率38.31%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800029062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644465706","title":"富祥股份涨6.92%，华鑫证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2644465706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644465706?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:44","pubTimestamp":1781772286,"startTime":"0","endTime":"0","summary":"今日富祥股份涨6.92%，收盘报19.48元。2026年3月27日，华鑫证券研究员胡博新发布了对富祥药业的研报《公司事件点评报告：新业务迎来收获阶段，业绩大幅扭亏》，该研报对富祥药业给出“买入”评级。研报中预测公司2025-2027年收入分别为11.86、21.63、23.64亿元，EPS分别为-0.09、1.11、1.16元，当前股价对应PE分别为-195.8、16.6、15.9倍，考虑到新能源业务的持续扭亏以及微生物蛋白项目投产，首次覆盖，给予“买入”投资评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300497"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644077703","title":"富祥股份(300497.SZ)发预盈，预计上半年归母净利润1.65亿元至2.15亿元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2644077703","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644077703?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:07","pubTimestamp":1781770046,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥股份(300497.SZ)发布2026年半年度业绩预告，预计上半年归属于上市公司股东的净利润1.65亿元至2.15亿元，同比扭亏为盈。报告期内，公司紧抓市场机遇，将电解液添加剂VC产品产能增加至10,000吨/年，同时FEC产品产能约4,000吨/年。2026年上半年公司前述产品销售量价齐增，推动公司业绩大幅增长且扭亏为盈。新能源业务已成为公司业绩增长的核心引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"富祥股份(300497.SZ)发预盈，预计上半年归母净利润1.65亿元至2.15亿元，同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300497"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644792327","title":"富祥股份：《电动汽车用动力蓄电池安全要求》（GB 38031-2025）将于2026年7月1日起正式实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2644792327","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644792327?lang=zh_cn&edition=full","pubTime":"2026-06-18 11:34","pubTimestamp":1781753651,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥股份06月17日在投资者关系平台上答复投资者关心的问题。投资者提问：市场关于7 月 1 日强制执行的动力电池新国标对 VC添加剂构成确定性强利好的说法是对的吗？《电动汽车用动力蓄电池安全要求》将于2026年7月1日起正式实施。公司目前具有10,000吨/年VC和约4,000吨/年FEC产品产能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800017122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643739241","title":"富祥股份：公司是国内舒巴坦领域唯一通过国际规范市场认证的供应商","url":"https://stock-news.laohu8.com/highlight/detail?id=2643739241","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643739241?lang=zh_cn&edition=full","pubTime":"2026-06-14 19:32","pubTimestamp":1781436720,"startTime":"0","endTime":"0","summary":"证券日报网6月14日讯，富祥股份在接受调研者提问时表示， 医药制造业务方面，公司是国内舒巴坦领域唯一通过国际规范市场认证的供应商，产品质量与成本控制能力位居行业前列；同时，公司也是他唑巴坦全球主要供应商之一，是国内为数不多实现从起始原料到下游原料药全产业链布局的碳青霉烯类培南系列产品生产商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrir8882259.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrir8882259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300497","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241751","title":"富祥股份：2022年至2025年，公司累计研发投入约3.09亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241751","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643241751?lang=zh_cn&edition=full","pubTime":"2026-06-14 19:32","pubTimestamp":1781436720,"startTime":"0","endTime":"0","summary":"证券日报网6月14日讯，富祥股份在接受调研者提问时表示，公司高度重视技术创新，持续保持较高强度的研发投入。2022年至2025年，公司累计研发投入约3.09亿元，为医药制造、新能源锂电池电解液添加剂及生物制造微生物蛋白三大业务的技术研发和工艺优化提供了有力支撑。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrir8882252.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrir8882252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300497","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241738","title":"富祥股份：聚焦高附加值原料药，持续深耕、巩固并扩大在既有医药领域的优势地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241738","media":"证券日报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643241738?lang=zh_cn&edition=full","pubTime":"2026-06-14 19:32","pubTimestamp":1781436720,"startTime":"0","endTime":"0","summary":"证券日报网6月14日讯，富祥股份在接受调研者提问时表示，展望未来，公司的战略定位清晰明确。医药制造业务将作为基本盘，聚焦高附加值原料药，持续深耕、巩固并扩大在既有医药领域的优势地位。新能源锂电池电解液添加剂业务将着力打造一站式原料供应平台，为客户提供更丰富产品矩阵与更稳定的供应保障。生物制造微生物蛋白业务则将实行B端与C端双轮驱动：在B端，向下游食品企业提供未冉蛋白原料及整体食品解决方案；在C端，通过自有品牌及联营品牌进行终端市场拓展。通过三大业务协同发展，致力于成为守护地球环境和人类健康的领先企业。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickriq7335299.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickriq7335299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","BK0239","BK0201","300497","BK1161","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241205","title":"富祥股份：公司是国内首家实现丝状真菌蛋白千吨级产业化的企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241205","media":"证券日报网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643241205?lang=zh_cn&edition=full","pubTime":"2026-06-14 19:32","pubTimestamp":1781436720,"startTime":"0","endTime":"0","summary":"公司是国内首家实现丝状真菌蛋白千吨级产业化的企业，核心产品未冉蛋白已通过国家卫健委新食品原料审批，成为我国首个获批的丝状真菌蛋白，同时获得美国SELF-GRAS认证，实现中美双认证。在技术层面，公司拥有完全自主知识产权的新型生产菌株，相关关键技术经中国轻工业联合会鉴定达到国际先进水平，其中菌种选育技术达到国际领先水平，并已获得中国、美国、韩国发明专利授权。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrit5658326.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrit5658326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0201","300497","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643124173","title":"富祥股份：到2035年全球替代蛋白市场规模有望达到2900亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643124173","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643124173?lang=zh_cn&edition=full","pubTime":"2026-06-14 19:32","pubTimestamp":1781436720,"startTime":"0","endTime":"0","summary":"证券日报网6月14日讯，富祥股份在接受调研者提问时表示，公司未冉蛋白具有干净、战略、未来的属性，契合消费者对健康、可持续蛋白来源的需求。根据波士顿咨询公司(BCG)报告预测，到2035年全球替代蛋白市场规模有望达到2900亿美元，其中微生物蛋白将占据约22%的份额，市场空间广阔。与此同时，国家层面出台了多项支持政策，如国家“十五五”规划明确提出要拓展新型蛋白来源，为公司微生物蛋白业务的发展提供了良好的政策环境。在此背景下，公司正积极推动未冉蛋白走向国内及国际市场，未来有望在政策支持与市场需求的双重驱动下实现快速放量，成为公司业绩增长的重要引擎。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrit5658334.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-14/doc-inickrit5658334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300497","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641356174","title":"【机构调研记录】东北证券调研富祥股份、凌玮科技等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2641356174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641356174?lang=zh_cn&edition=full","pubTime":"2026-06-08 08:02","pubTimestamp":1780876926,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月5日披露的机构调研信息，东北证券近期对4家上市公司进行了调研。调研上市公司名单如下：1）富祥股份 个股亮点：公司目前已具备年产8000吨碳酸亚乙烯酯和3700吨氟代碳酸乙烯酯产品产能，产能规模及产品出货量居行业前列。4）聚飞光电 个股亮点：公司客户主要是通讯设备服务商及数据中心等公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800000257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","BK0183","BK0229","BK0028","301373","000686","300497","BK0276","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641317484","title":"【机构调研记录】宏利基金调研富祥股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641317484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641317484?lang=zh_cn&edition=full","pubTime":"2026-06-08 08:01","pubTimestamp":1780876906,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月5日披露的机构调研信息，宏利基金近期对1家上市公司进行了调研，相关名单如下：1）富祥股份 个股亮点：公司目前已具备年产8000吨碳酸亚乙烯酯和3700吨氟代碳酸乙烯酯产品产能，产能规模及产品出货量居行业前列。旗下最近一年表现最佳的公募基金产品为宏利成长混合，最新单位净值为7.68，近一年增长290.97%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800000228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300497","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641748491","title":"【私募调研记录】中欧瑞博调研富祥股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641748491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641748491?lang=zh_cn&edition=full","pubTime":"2026-06-08 08:01","pubTimestamp":1780876881,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月5日披露的机构调研信息，知名私募中欧瑞博近期对1家上市公司进行了调研，相关名单如下：1）富祥股份 个股亮点：公司目前已具备年产8000吨碳酸亚乙烯酯和3700吨氟代碳酸乙烯酯产品产能，产能规模及产品出货量居行业前列。中欧瑞博从事证券私募基金管理业务，专注于二级市场证券投资。取名\"兔子基金\"体现了中欧瑞博敬畏风险的投资文化，并始终把风险防范和管理摆在突出位置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026060800000188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783318806383,"stockEarnings":[{"period":"1week","weight":0.0581},{"period":"1month","weight":0.362},{"period":"3month","weight":0.2329},{"period":"6month","weight":0.4467},{"period":"1year","weight":1.3531},{"period":"ytd","weight":0.4467}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西富祥药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"51274人(较上一季度增加38.56%)","perCapita":"8825股","listingDate":"2015-12-22","address":"江西省景德镇市昌江区鱼丽工业区2号(鱼山与丽阳交界处)","registeredCapital":"53864万元","survey":" 江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售。公司的主要产品是β-内酰胺酶抑制剂、碳青霉烯类（培南系列）药物、抗病毒药物中间体、碳酸亚乙烯酯（VC）、氟代碳酸乙烯酯（FEC）、微生物蛋白、氨基酸水溶肥。公司未冉蛋白成功入选国家工信部首批“生物制造标志性产品”，并荣获“十四五”轻工业先进科技创新成果目录认定。","listedPrice":15.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"富祥股份(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供富祥股份(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"富祥股份,300497,富祥股份股票,富祥股份股票老虎,富祥股份股票老虎国际,富祥股份行情,富祥股份股票行情,富祥股份股价,富祥股份股市,富祥股份股票价格,富祥股份股票交易,富祥股份股票购买,富祥股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"富祥股份(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供富祥股份(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}